Literature DB >> 27893750

Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.

Renata R Gomes1,2, Vania A Vicente1, Conceição M P S de Azevedo3, Claudio G Salgado4, Moises B da Silva4, Flávio Queiroz-Telles1,5, Sirlei G Marques6,7, Daniel W C L Santos8, Tania S de Andrade9, Elizabeth H Takagi9, Katia S Cruz10, Gheniffer Fornari1, Rosane C Hahn11, Maria L Scroferneker12, Rachel B Caligine13, Mauricio Ramirez-Castrillon14, Daniella P de Araújo4, Daiane Heidrich15, Arnaldo L Colombo8, G S de Hoog1,16.   

Abstract

The human mutilating disease chromoblastomycosis is caused by melanized members of the order Chaetothyriales. To assess population diversity among 123 clinical strains of agents of the disease in Brazil we applied sequencing of the rDNA internal transcribed spacer region, and partial cell division cycle and β-tubulin genes. Strains studied were limited to three clusters divided over the single family Herpotrichiellaceae known to comprise agents of the disease. A Fonsecaea cluster contained the most important agents, among which F. pedrosoi was prevalent with 80% of the total set of strains, followed by 13% for F. monophora, 3% for F. nubica, and a single isolate of F. pugnacius. Additional agents, among which two novel species, were located among members of the genus Rhinocladiella and Cyphellophora, with frequencies of 3% and 1%, respectively.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27893750      PMCID: PMC5125572          DOI: 10.1371/journal.pntd.0005102

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


Introduction

Chromoblastomycosis is a chronic granulomatous infection of the skin caused by melanized fungi. It has a worldwide distribution mainly in tropical and subtropical climate zones, with a preference for humid climates with dense forestation, with Cladophialophora carrionii being the only species that is restricted to semi-arid areas with Cactaceae as main vegetation. Endemic areas are in Japan, Southeast Asia, Australia, Madagascar, as well as South and Central America [1-7]. In Brazil, the infection is observed in all states, with an estimated prevalence of 1/196 thousand inhabitants, but in some hyperendemic regions a considerably higher prevalence is noted [8]. Infection is assumed to occur through accidental inoculation of the fungus via contaminated plant debris, being favored by agricultural activities denoting an occupational nature of the disease. Chromoblastomycosis is one of the most frequent implantation mycoses found among rural populations [2, 8–11]. Clinically, the disease is characterized by pseudoepitheliomatous hyperplasia with epidermal microabscesses and dermal granulomata [12, 13]. The disease has a slow evolution, but finally may result in disfigurement of affected body sites [8]. The initial lesion is noted as a small pink papule at the site of inoculation which gradually enlarges. Development of superficial erythematous plaques with scaly or warty appearance probably takes several months or years. As a result of acanthosis these lesions may develop into large papillomatous and verrucous warts. Species of the humid climate are particularly members of the genus Fonsecaea, with F. pedrosoi, F. monophora and F. nubica as prevalent agents [14-17]. Recently another species, F. pugnacius was described [18]. Rhinocladiella aquaspersa is an uncommon species of humid as well as of dry climates [19]. Other reported agents such as Phialophora verrucosa and Exophiala dermatitidis [17, 20] are extremely rare and mostly cause other types of infections. Fonsecaea pedrosoi is nearly exclusively isolated from chromoblastomycosis, while F. monophora repeatedly causes brain infection and F. pugnacius combines the two disorders by starting as chromoblastomycosis with cerebral dissemination in a single patient [18]. Species distinction of agents of the disease is clinically significant because of the differences in prognosis of the infection. The present study evaluates the diversity of agents in endemic areas of Brazil based on multilocus sequence data, clinical aspects, direct mycological examination and culture. An enumeration of currently proven cases with molecular support in endemic areas in Brazil is provided.

Results

A set of 123 clinical strains from cases of chromoblastomycosis from different endemic areas in Brazil was analyzed. Judging from a reference set of partial LSU rDNA sequences of members of Chaetothyriales available at CBS, agents of chromoblastomycosis were polyphyletic within the order, being dispersed in three different clades: jeanselmei-, bantiana- and europaea-clades (Fig 1, arrows).
Fig 1

Phylogeny of a representative selection of species in Chaetothyriales, based on confidently aligned LSU sequences.

Constructed with Maximum likelihood implemented in MEGA 7. Bootstrap values > 80% from 100 resampled datasets are shown with branches. Coloured boxes represent species complexes taken from de Hoog et al. [21], Feng et al. [22], and Vicente et al. [23]. Clades with species causing chromoblastomycosis analysed in this study are indicated with arrows. Type strain in bold.

Phylogeny of a representative selection of species in Chaetothyriales, based on confidently aligned LSU sequences.

Constructed with Maximum likelihood implemented in MEGA 7. Bootstrap values > 80% from 100 resampled datasets are shown with branches. Coloured boxes represent species complexes taken from de Hoog et al. [21], Feng et al. [22], and Vicente et al. [23]. Clades with species causing chromoblastomycosis analysed in this study are indicated with arrows. Type strain in bold. Multilocus sequence analyses using ITS, and partial BT2 and CDC42 genes were performed for identification and for elucidation of species identities (S1 Fig). The 123 clinical strains clustered in different clades within the Chaetothyriales, being centred around members of the genera Fonsecaea, Rhinocladiella, and Cyphellophora (Table 1). The Brazilian clinical isolates used in this study all were derived from humid climate zones; members of the Cladophialophora carrionii group were not encountered.
Table 1

Strains analysed.

NameStrain numberGeograph/ BrazilChromoblastomycose lesionsITS; BT2; CDC42; LSU
Fonsecaea monophoraCMRP1290MA, NortheastPolymorphic lesionsKR732306; KR732312; KR732318
Fonsecaea monophoraCMRP1329PR, NorthPlaqueKX434631; KX583711
Fonsecaea monophoraCMRP1330PR, NorthNodularKX434632
Fonsecaea monophoraCMRP1359AM, NorthNIKX434633
Fonsecaea monophoraCMRP1360AM, NorthNIKX434634
Fonsecaea monophoraCMRP1335MG, SoutheastNIKX434639
Fonsecaea monophoraCMRP1366PR, SouthPolymorphic lesionsKX434635
Fonsecaea monophoraCMRP1367RS, SouthNIKX434636
Fonsecaea monophoraCMRP1368RS, SouthNIKX434637
Fonsecaea monophoraCMRP1369RS, SouthNIKX434638
Fonsecaea monophoraCMRP1371PR, SouthNIKX434640
Fonsecaea monophoraCMRP1383PR, SouthNIKX434641
Fonsecaea monophoraCBS 102242PR, SouthVerrucousEU938583; EU938549
Fonsecaea monophoraCBS 102243PR, SouthScarringEU938579; EU938542
Fonsecaea monophoraCBS 102246PR, SouthNIAY366928; EU938543
Fonsecaea monophoraCBS 102248PR, SouthNIAY366926; EU938550
Fonsecaea nubicaIAL 4004BA, NortheastVerrucousKU892412
Fonsecaea nubicaIAL 3994RO, NorthVerrucousKU881739
Fonsecaea nubicaIAL 3992MG, SoutheastNodular and tumoralKU881735
Fonsecaea nubicaIAL 3999SP, SoutheastPolymorphic lesionsKU8811742
Fonsecaea pedrosoiCMRP1342MA, NortheastNIKX434642
Fonsecaea pedrosoiCMRP1271MA, NortheastPolymorphic lesionsKR732301; KR732307; KR732313
Fonsecaea pedrosoiCMRP1272MA, NortheastNodular and plaqueKR732302; KR732308; KR732314
Fonsecaea pedrosoiCMRP1273MA, NortheastPlaqueKR732303; KR732309; KR732315
Fonsecaea pedrosoiCMRP1274MA, NortheastNodular and plaqueKR732304; KR732310; KR732316
Fonsecaea pedrosoiCMRP1275MA, NortheastPlaqueKR732305; KR732311; KR732317
Fonsecaea pedrosoiCMRP1276MA, NortheastScarring, nodular and plaqueKX434643; -; KX583684
Fonsecaea pedrosoiCMRP1277MA, NortheastPlaqueKX434644; KX583712; KX583685
Fonsecaea pedrosoiCMRP1278MA, NortheastScarring and plaqueKX434645; KX583713; KX583686
Fonsecaea pedrosoiCMRP1279MA, NortheastPlaqueKX434646; -; KX583687
Fonsecaea pedrosoiCMRP1280MA, NortheastNodular and plaqueKX434647; KX583714; KX583688
Fonsecaea pedrosoiCMRP1281MA, NortheastNodular and plaqueKX434648
Fonsecaea pedrosoiCMRP1282MA, NortheastNodular and plaqueKX434649; -; KX583689
Fonsecaea pedrosoiCMRP1283MA, NortheastNodular and plaqueKX434650; -; KX583690
Fonsecaea pedrosoiCMRP1284MA, NortheastPlaqueKX434651; KX583715; KX583691
Fonsecaea pedrosoiCMRP1285MA, NortheastPlaqueKX434652; -; KX583692
Fonsecaea pedrosoiCMRP1286MA, NortheastScarring, nodular and plaqueKX434653; KX583716
Fonsecaea pedrosoiCMRP1288MA, NortheastScarring and plaqueKX434654; KX583717; KX583693
Fonsecaea pedrosoiCMRP1289MA, NortheastPlaqueKX434655; -; KX583694
NameStrain numberGeograph/ BrazilChromoblastomycose lesionsITS; BT2; CDC42; LSU
Fonsecaea pedrosoiCMRP1291MA, NortheastPlaqueKX434656; KX583718; KX583695
Fonsecaea pedrosoiCMRP1292MA, NortheastPlaqueKX434657; KX583719; KX583696
Fonsecaea pedrosoiCMRP1293MA, NortheastPlaqueKX434658; KX583720; KX583697
Fonsecaea pedrosoiCMRP1294MA, NortheastScarring and plaqueKX434659; KX583721; KX583698
Fonsecaea pedrosoiCMRP1295MA, NortheastScarring and plaqueKX434660; -; KX583699
Fonsecaea pedrosoiCMRP1296MA, NortheastScarring, nodular and plaqueKX434661; -; KX583700
Fonsecaea pedrosoiCMRP1298MA, NortheastPlaqueKX434662; KX583722
Fonsecaea pedrosoiCMRP1299MA, NortheastPlaqueKX434663; KX583723
Fonsecaea pedrosoiCMRP1300MA, NortheastScarring, nodular and plaqueKX434664
Fonsecaea pedrosoiCMRP1301MA, NortheastPlaqueKX434665; KX583724; KX583701
Fonsecaea pedrosoiCMRP1302MA, NortheastScarring, nodular and plaqueKX434666; KX583725; KX583702
Fonsecaea pedrosoiCMRP1303MA, NortheastPlaqueKX434667
Fonsecaea pedrosoiCMRP1304MA, NortheastPolymorphic lesionsKX434668; KX583726; KX583703
Fonsecaea pedrosoiCMRP1305MA, NortheastNodular and plaqueKX434669; KX583727; KX583704
Fonsecaea pedrosoiCMRP1306MA, NortheastNodular, verrucous and plaqueKX434670; KX583728; KX583705
Fonsecaea pedrosoiCMRP1308MA, NortheastPlaqueKX434671; KX583729; KX583706
Fonsecaea pedrosoiCMRP1309MA, NortheastScarring and plaqueKX434672; KX583730; KX583707
Fonsecaea pedrosoiCMRP1310MA, NortheastPlaqueKX434673
Fonsecaea pedrosoiCMRP1311MA, NortheastPlaqueKX434674; KX583731
Fonsecaea pedrosoiCMRP1313MA, NortheastPlaqueKX434675; KX583732
Fonsecaea pedrosoiCMRP1314MA, NortheastNIKX434676; KX583733
Fonsecaea pedrosoiCMRP1315MA, NortheastNodular, tumoral and plaqueKX434677; KX583734
Fonsecaea pedrosoiCMRP1316MA, NortheastPlaqueKX434678
Fonsecaea pedrosoiCMRP1318MA, NortheastNIKX434679
Fonsecaea pedrosoiIAL 3991BA, NortheastVerrucousKU881737
Fonsecaea pedrosoiIAL 3997BA, NortheastVerrucousKU881741
Fonsecaea pedrosoiIAL 3996BA, NortheastVerrucousKU881745
Fonsecaea pedrosoiCMRP1331PA, NorthNodularKX434680
Fonsecaea pedrosoiCMRP1332PA, NorthNodularKX434681; KX583735
Fonsecaea pedrosoiCMRP1333PA, NorthNodularKX434682
Fonsecaea pedrosoiCMRP1334PA, NorthNodularKX434683; KX583736
Fonsecaea pedrosoiCMRP1337PA, NorthNodularKX434684
Fonsecaea pedrosoiCMRP1338PA, NorthNodularKX434685; KX583737
Fonsecaea pedrosoiCMRP1339PA, NorthNodularKX434686; KX583738
Fonsecaea pedrosoiCMRP1340PA, NorthNodularKX434687; KX583739
Fonsecaea pedrosoiCMRP1341PA, NorthNodularKX434688; KX583752
Fonsecaea pedrosoiCMRP1344PA, NorthNodularKX434689; KX583740
Fonsecaea pedrosoiCMRP1345PA, NorthNodularKX434690
Fonsecaea pedrosoiCMRP1346PA, NorthNodularKX434691; KX583741
Fonsecaea pedrosoiCMRP1347PA, NorthNodularKX434692
Fonsecaea pedrosoiCMRP1348PA, NorthNodularKX434693; KX583742
Fonsecaea pedrosoiCMRP1349PA, NorthNodularKX434694
Fonsecaea pedrosoiCMRP1350PA, NorthNodularKX434695; KX583743
Fonsecaea pedrosoiCMRP1351PA, NorthPlaqueKX434696; KX583744
Fonsecaea pedrosoiCMRP1352PA, NorthNodularKX434697; KX583745
Fonsecaea pedrosoiCMRP1353PA, NorthNodularKX434698; KX583746
Fonsecaea pedrosoiCMRP1354PA, NorthNodularKX434699
Fonsecaea pedrosoiCMRP1355PA, NorthNodularKX434700; KX583747
Fonsecaea pedrosoiCMRP1356PA, NorthNodularKX434701
Fonsecaea pedrosoiCMRP1357PA, NorthNodularKX434702; KX583748
NameStrain numberGeograph/ BrazilChromoblastomycose lesionsITS; BT2; CDC42; LSU
Fonsecaea pedrosoiCMRP1361PA, NorthNodularKX434703
Fonsecaea pedrosoiIAL 3998RO, NorthNodular and tumoralKU881736
Fonsecaea pedrosoiIAL 4001RO, NorthVerrucousKU881744
Fonsecaea pedrosoiIAL 4005RO, NorthPolymorphic lesionsKU892413
Fonsecaea pedrosoiIAL 4007RO, NorthVerrucousKU892414
Fonsecaea pedrosoiCMRP1336MG, SoutheastNIKX434709
Fonsecaea pedrosoiCMRP1362MS, SoutheastNIKX434704
Fonsecaea pedrosoiCMRP1363MS, SoutheastNIKX434705
Fonsecaea pedrosoiCMRP1364MS, SoutheastNIKX434706
Fonsecaea pedrosoiCMRP1365MS, SoutheastNIKX434707
Fonsecaea pedrosoiIAL 3993MG, SoutheastNodular and tumoralKU881738
Fonsecaea pedrosoiCMRP1372PR, SouthNodular and verrucousKX434710
Fonsecaea pedrosoiCMRP1384PR, SouthNodular and verrucousKX434717
Fonsecaea pedrosoiCMRP1373PR, SouthScarringKX434711
Fonsecaea pedrosoiCMRP1374PR, SouthScarring and verrucousKX434712
Fonsecaea pedrosoiCMRP1375PR, SouthNodular and verrucousKX434713
Fonsecaea pedrosoiCMRP1376PR, SouthVerrucousKX434714
Fonsecaea pedrosoiCBS 102245PR, SouthScarring and verrucousAY366918; EU938562
Fonsecaea pedrosoiCBS 102247PR, SouthNIAY366919; EU938566
Fonsecaea pedrosoiCMRP1377PR, SouthVerrucousKX434715
Fonsecaea pedrosoiCMRP1378PR, SouthPlaqueKX434720
Fonsecaea pedrosoiCMRP1379PR, SouthPolymorphic lesionsKX434721
Fonsecaea pedrosoiCMRP1380PR, SouthNodular and tumoralKX434716
Fonsecaea pedrosoiCMRP1381PR, SouthNodular and tumoralKX434718
Fonsecaea pedrosoiCMRP1382PR, SouthNIKX434719
Fonsecaea pedrosoiCMRP1370RS, SouthNIKX434708
Fonsecaea pedrosoiIAL 4000NIPolymorphic lesionsKU881743
Fonsecaea pedrosoiIAL 4006NIVerrucousKU892409
Fonsecaea pedrosoiIAL 4002NIVerrucousKU892410
Fonsecaea pugnaciusCBS 139214MA, NortheastPlaque and disseminated to brainKR706553; KR706547; KR706551
Cyphellophora ludoviensis sp. nov.CMRP1317MA, NortheastNodular and plaqueKX434722; KX583749; -; KX583708
Rhinocladiella tropicalis sp. nov.CMRP1287MA, NortheastPolymorphic lesionsKX434723; KX583750; -; KX583709
Rhinocladiella tropicalisCMRP1307MA, NortheastPlaqueKX434724; KX583751; -; KX583710
Rhinocladiella tropicalisIMT776SP, SouthNIKU854928

CMRP, Microbial Collections of Paraná Network- TAXon line; CBS, CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands; IMT, Tropical Medicine Institute, SP, Brazil; IAL, Culture Collection of Adolfo Lutz Institute. BT2, partial beta-tubulin gene; ITS, internal transcribed spacer regions of the rDNA and intervening 5.8S nuclear ribosomal DNA (nrDNA); CDC42, partial cell division cycle gene. Brazil Sates: BA. Bahia; MA. Maranhão; MG. Minas Gerais; MS. Mato Grosso do Sul; PA. Para; RO. Rondônia; PR. Paraná; RS. Rio Grande do Sul; SP. São Paulo; NI. not informed, patients in treatment at SP.

CMRP, Microbial Collections of Paraná Network- TAXon line; CBS, CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands; IMT, Tropical Medicine Institute, SP, Brazil; IAL, Culture Collection of Adolfo Lutz Institute. BT2, partial beta-tubulin gene; ITS, internal transcribed spacer regions of the rDNA and intervening 5.8S nuclear ribosomal DNA (nrDNA); CDC42, partial cell division cycle gene. Brazil Sates: BA. Bahia; MA. Maranhão; MG. Minas Gerais; MS. Mato Grosso do Sul; PA. Para; RO. Rondônia; PR. Paraná; RS. Rio Grande do Sul; SP. São Paulo; NI. not informed, patients in treatment at SP. Fonsecaea is nested in the ‘bantiana-clade’ (Table 1) and contains the prevalent agents of the disease. Of the studied isolates, 98 (80%) grouped as Fonsecaea pedrosoi, followed by 16 (13%) isolates of F. monophora, 4 (3%) isolates of F. nubica and one isolate of F. pugnacius. Isolates of the Rhinocladiella group and of phialophora-like species are considered as rare agents of chromoblastomycosis in the Americas. Rhinocladiella was nested in the ‘jeanselmei-clade’ and the phialophora-like agent clustered in the ‘europaea-clade’ (presently known as Cyphellophoraceae); two unnamed species were uncovered (Fig 1). The analyzed ITS and BT2 regions and a tree resulting from combined loci revealed identical topologies in phylogenetic analyses. The unnamed strains CMRP1287, CMRP1307, IMT776 and CMRP1317 were found to be concordantly positioned in all trees and grouped with remaining members of Rhinocladiella and Cyphellophora causing chromoblastomycosis (Figs 2 and 3). Clinical strain CMRP1317 was located at a significant distance from all reference strains of Cyphellophora, i.e with combined ITS and BT2 data the distance was 23.4%. Strains CMRP1287, CMRP1307 and IMT776 were also located at significant distance from known species in Rhinocladiella (Table 2). Consequently the strains were judged to represent novel taxa in Cyphellophora and Rhinocladiella, respectively.
Fig 2

Multilocus tree of Cyphellophora based on ITS and partial BT2 sequences.

Constructed with maximum likelihood implemented in MEGA 7. Bootstrap values of >80% from 100 resampled data sets are shown with branches. Cladophialophora yegresii and C. carrionii comprised the outgroup. Novel species causing chromoblastomycosis are indicated with red branches. Type strain in bold.

Fig 3

Multilocus tree of Rhinocladiella based on ITS and partial BT2 sequences.

Constructed with maximum likelihood implemented in MEGA 7. Bootstrap values of >80% from 100 resampled data sets are shown with branches. Cladophialophora yegresii and C. carrionii comprised the outgroup. Novel species causing chromoblastomycosis are indicated with red branches. Type strain in bold.

Table 2

Estimates of Evolutionary Divergence of Rhinocladiella tropicalis.

Distance R. aquaspersa to R. phaeophora ITS (4.5) and BT2 (5.6); Lengths of alignments of ITS: 548 bp and BT2: 349 bp. Analyses were conducted using the Kimura 2-parameter model. All ambiguous positions were removed for each sequence pair. Evolutionary analyses were conducted in MEGA 7.

LocusR. aquaspersaR. phaeophoraR. fasciculataR. atrovirensR. mackenzieR. ancepsR. basitonaR. similis
ITS5.15.411.418.619.720.421.722.0
BT29.710.7----------------34.836.5

Multilocus tree of Cyphellophora based on ITS and partial BT2 sequences.

Constructed with maximum likelihood implemented in MEGA 7. Bootstrap values of >80% from 100 resampled data sets are shown with branches. Cladophialophora yegresii and C. carrionii comprised the outgroup. Novel species causing chromoblastomycosis are indicated with red branches. Type strain in bold.

Multilocus tree of Rhinocladiella based on ITS and partial BT2 sequences.

Constructed with maximum likelihood implemented in MEGA 7. Bootstrap values of >80% from 100 resampled data sets are shown with branches. Cladophialophora yegresii and C. carrionii comprised the outgroup. Novel species causing chromoblastomycosis are indicated with red branches. Type strain in bold.

Estimates of Evolutionary Divergence of Rhinocladiella tropicalis.

Distance R. aquaspersa to R. phaeophora ITS (4.5) and BT2 (5.6); Lengths of alignments of ITS: 548 bp and BT2: 349 bp. Analyses were conducted using the Kimura 2-parameter model. All ambiguous positions were removed for each sequence pair. Evolutionary analyses were conducted in MEGA 7. We report the clinical cases caused by the novel Cyphellophora and Rhinocladiella species, which are named below as C. ludoviensis and R. tropicalis, respectively. The species showed optimal development at 30°C and 27°C, respectively, with a wide growth range between 18°C and 37°C and with residual growth at 15°C and 38°C and maximum growth temperature at 37°C; no growth was observed at 40°C (Fig 4).
Fig 4

Cardinal temperatures of strains described.

(A) Cyphellophora ludoviensis with optimal growth temperature at 30°C and maximum at 37°C. (B) Rhinocladiella tropicalis with optimal development at 27°C and maximum at 37°C.

Cardinal temperatures of strains described.

(A) Cyphellophora ludoviensis with optimal growth temperature at 30°C and maximum at 37°C. (B) Rhinocladiella tropicalis with optimal development at 27°C and maximum at 37°C. C.M.P.S. Azevedo, R.R. Gomes, V.A. Vicente & de Hoog, sp. nov. ‒ MycoBank MB 817305 (Figs 2 and 5).
Fig 5

Cyphellophora ludoviensis microscopic morphology.

(A) colonies on SGA; (B-E) hyphae with chlamydospores and lateral extensions; (F) anastomosis; (G-H) spirally twisted hyphae; (I) poorly differentiated phialide producing conidia; (J-P) chlamydospores and conidia. Scale bars 10 μm.

Cyphellophora ludoviensis microscopic morphology.

(A) colonies on SGA; (B-E) hyphae with chlamydospores and lateral extensions; (F) anastomosis; (G-H) spirally twisted hyphae; (I) poorly differentiated phialide producing conidia; (J-P) chlamydospores and conidia. Scale bars 10 μm. Etymology: named after the city where the case was first diagnosed, San Luis in Maranhão State, Brazil. Holotype: Maranhão State, Brazil, from skin lesion of human patient, dried holotype UPCB 85592 at Department of Botany Herbarium at Federal University of Paraná (UPCB); type strain CMRP1317 = LMICRO356 = CBM47. Additional information listed in Table 1. Description of CMRP51317 after two weeks incubation on MEA at 28°C: Colonies moderately expanding, greyish olive to olivaceus black, with olivaceus black reverse. Hyphae pale olivaceous brown, 1.2–6 μm wide, septate every 9–25 μm, occasionally bearing scarce phialides and conidia. Phialides poorly differentiated, producing sub-spherical, hyaline conidia, 1.8−2.5 μm. Creeping hyphae producing lateral outgrowths which become septate, pale brown conidiophores 1.5−2.0 μm wide and with frequent anastomoses; chlamydospores developing intercalarily or terminally on hyphae. Chlamydospores ovoidal, brown, 4.5−6.5 × 4.5 μm, with irregularly thickened walls. Thickened terminal hyphae and spirally twisted hyphae frequently present. Teleomorph unknown. Cardinal temperatures: minimum 18°C, optimum 30°C, maximum 37°C, with residual growth at 15°C and 38°C. Case report: Patient, a 57-year-old Caucasian male from Icatu, Brazil, was diagnosed in 2008 with lower limb injuries with nodular appearance and plaque. Moderate disease progressed with 3 years of evolution; muriform cells were observed in tissue (Fig 6A and 6B). Patient was treated orally with itraconazole (200 mg/day), leading to improvement of the lesions during treatment within three months. Patient abandoned treatment after 12 months and returned in 2011 with recurred lesions spreading throughout the lower limb, following a lymphatic path, with secondary infections, presenting verrucous type injuries, ulceration and crusting at the surface. The fungus was re-isolated from the recurred lesions. The patient was treated using itraconazole (200 mg/day) combined with cryosurgery.
Fig 6

Clinical case pictures.

(A, B) Nodular and verrucous lesions and muriform cells from skin tissue biopsy of arm lesion caused by Cyphellophora ludoviensis (CMRP1317); (C-E) polymorphic infiltrative plaque lesions caused by different strains of Rhinocladiella tropicalis affecting the legs, (C) with nodular and cicatricial and (E) verrucous lesions; (D-F) muriform cells from skin tissue biopsy of lesions caused by R. tropicalis strains CMRP1287 and CMRP1307, respectively.

Clinical case pictures.

(A, B) Nodular and verrucous lesions and muriform cells from skin tissue biopsy of arm lesion caused by Cyphellophora ludoviensis (CMRP1317); (C-E) polymorphic infiltrative plaque lesions caused by different strains of Rhinocladiella tropicalis affecting the legs, (C) with nodular and cicatricial and (E) verrucous lesions; (D-F) muriform cells from skin tissue biopsy of lesions caused by R. tropicalis strains CMRP1287 and CMRP1307, respectively. Notes: The strain clustered with members of Chaetothyriales variously classified in Cyphellophora or Phialophora. Several of these have been reported from mild infections of human skin but without presence of muriform cells. Cyphellophora ludoviensis is the only species in the ‘europaea-clade’ (Cyphellophoraceae) where muriform cells were observed in the lesions, and is distant from remaining species causing this disease, as well as from the generic type of Phialophora, P. verrucosa. C.M.P.S. Azevedo, R.R. Gomes, V.A. Vicente & de Hoog, sp. nov. ‒ MycoBank MB 817306 (Figs 3 and 7).
Fig 7

Rhinocladiella tropicalis, microscopic morphology.

(A) Colonies on SGA; (B, C) twisted hyphae and conidia; (D-G) conidiophores with conidia produced in sympodial order; (H-O) conidial apparatus with conidia. Scale bars 10 μm.

Rhinocladiella tropicalis, microscopic morphology.

(A) Colonies on SGA; (B, C) twisted hyphae and conidia; (D-G) conidiophores with conidia produced in sympodial order; (H-O) conidial apparatus with conidia. Scale bars 10 μm. Etymology: Named after its occurrence in tropical South America. Holotype: Maranhão State, Brazil, from skin lesion of human patient, dried holotype UPCB 85593 at Department of Botany Herbarium at Federal University of Paraná (UPCB); type strain CMRP1287 = LMICRO326 = CBM17. Additional material examined listed in Table 1. Description of CMRP1287 after two weeks incubation on MEA at 28°C: Colonies growing moderate rapidly, velvety, elevated, olivaceus black with dark reverse. Mycelium partly immersed but mainly aerial, composed of branched hyphae which are pale brown, occasionally reddish brown, 1.5–2.5 μm wide, regularly septate every 7–18 μm, with integrated conidiogenous cells which are somewhat differentiated from vegetative hyphae. Conidiophores erect, straight, thick-walled, brown to dark brown, up to 19 μm high, bearing small, pigmented denticles on which conidia are produced in sympodial order. Conidiogenous cells terminal or lateral, often becoming intercalary, cylindrical in the apical part with numerous flat scars. Conidia one-celled, hyaline to pale brown, ellipsoidal to clavate, 2.5−5.0 × 1.5−2.5 μm; scars slightly prominent, approx. 0.4 μm diam, pigmented. Conidia usually 1-septate, 5−8 × 1.5−3.0 μm. Budding cells developing from single conidia may be present. Teleomorph unknown. Cardinal temperatures: minimum 18°C, optimum 27°C, maximum 37°C, with residual growth at 15°C. Case reports: Patient infected by R. tropicalis CMRP1287 was a 65-year-old caucasian male from Pinheiro, Maranhão, Brazil, diagnosed in 2004 with lower limb injuries showing polymorphic lesions with plaques and nodular and cicatrized lesions. Muriform cells were observed in tissue (Fig 6C and 6D). The infection evolved during a 6-year period. Treatment was started with itraconazole (200 mg/day), irregularly until 2012; subsequently regular treatment was installed but with low response. From then onwards additional cryosurgery with liquid nitrogen was applied once a week. After 4 years of therapy still some lesions with a fibrotic aspect and with few murifom cells were observed. Patient infected by R. tropicalis CMRP1307 strain was a 78-year-old afrodescendant male, from Icatu, Maranhão, Brazil, diagnosed in 2002 with lower limb injuries showing polymorphic lesions with plaques and infiltration and muriform cells in tissue (Fig 6E and 6F). The diseased showed moderate development over a 3-year period of evolution. Patient was treated with oral itraconazole (200 mg/day), initiated in 2010. Some treatment interruptions occurred because of the distance to the patient’s living place and the low response to itraconazole, with worsening of the symptoms. Both patients are still under treatment in 2016. The patient infected by R. tropicalis CMRP1287 is currently treated using itraconazole (200 mg/day) combined with cryosurgery and the patient infected by R. tropicalis CMRP1307 uses the antifungals itraconazole (400 mg/day) and terbinafin (250 mg twice daily) in combination. During our studies we noticed strain IMT766, isolated in 1970 from a case of chromoblastomycosis and deposited in the Institute of Tropical Medicine, São Paulo, Brazil, and supplementary material from a patient infected by strain CBS 132913, a 63-year-old male construction worker from Venezuela with an asymptomatic and localized skin lesion of the hand with a scaly, crusted, dull-red appearance, friable with hemorrhagic dots [19]. The response to treatment has been evaluated by clinical, mycological and histopathological criteria. A complete clinical response is being accompanied assuming for cure criteria after two years follow up without recurrence, with complete healing of the lesions and disappearance of itching and local pain. The patients must also be monitored by three to four consecutive biopsies to access the mycological and histopathological criteria of cure. A mycological response will be achieved after no observation of fungal elements upon direct examination and failure to isolate the causal agent from tissue fragments. Notes: With LSU rDNA the novel species clusters close to Rhinocladiella aquaspersa and R. phaeophora in the ‘jeanselmei clade’ in Herpotrichiellaceae (Fig 1). Members of this cluster are morphologically outstanding by stiff, erect conidiophores packed with sympodial, non-catenate conidia. With ITS (Fig 3), distances of 5.1% were noted between R. tropicalis and R. aquaspersa, and 5.4% with R. phaeophora (Table 2), underlining that a complex of sibling species is concerned.

Discussion

In this study, we describe two novel species of black fungi causing chromoblastomycosis infections. Among a set of 123 strains from cases of this disease, representatives of three genera were recognized, i.e. Fonsecaea, Rhinocladiella, and Cyphellophora. No member of Cladophialophora was encountered, which is explained by climatic conditions, as C. carrionii is prevalent in arid environmental conditions. In Brazil C. carrionii is rarely reported [24, 25]. The prevalent species in humid tropical climates of South America remains Fonsecaea pedrosoi, followed by F. monophora [2], while the latter species is predominant in southern China [26]. All four species of genus Fonsecaea related to chromoblastomycosis were found in the Brazilian endemic area. Judging from literature data, F. pedrosoi and F. nubica seem to be pathogens that are strictly associated with chromoblastomycosis, while F. monophora and F. pugnacius show some degree of neurotropism eventually leading to dissemination to the brain and other organs [14, 27]. The genus Cyphellophora is characterized by phialides producing sickle-shaped, septate conidia [28]. The group clusters with some phialidic species with small, one-celled conidia. Although the generic type species of Phialophora, P. verrucosa clusters in the ‘carrionii-clade’ distant from Cyphellophora, Feng et al. [22] classified them in Phialophora on morphological criteria. Later Réblová et al. [29] took phylogeny as the leading principle and reclassified all species of the ‘europaea-clade’ in Cyphellophora, the only genus of the newly established family Cyphellophoraceae. Since the taxonomy of Chaetothyriales is in a flux with numerous species to be added, we judge establishment of categories above the species level premature. Currently, phylogenetic data do not match with any other criterion established thus far in Chaetothyriales [21], and therefore phylogenetic genera and families in this order inevitably will remain counterintuitive. Cyphellophora ludoviensis is not effective to produce conidia on common mycological media; it was placed in the genus based on DNA sequence analyses. Members of the genus Cyphellophora colonize different habitats including, in addition to humans, plant debris, ant nests and abiotic substrates [22]. Our species is genetically close to C. capiguarae, described as living in association with ants (Atta capiguara), and to C. oxyspora from decaying leaves [30, 31]. Other members of Cyphellophora originate from mild cutaneous infections in humans, mostly from skin and nails [22]. Cyphellophora europaea in particular has been encountered globally as an agent of mild skin disease and onychomycosis [31] and was noted co-occurring with dermatophytes, mainly Trichophyton rubrum affecting the skin of diabetic patients [32]. Environmental strains of this species were found in indoor wet cells, such as bathrooms and washing machines [33, 34]. Cyphellophora ludoviensis is the first species in the Cyphellophoraceae that had muriform cells in tissue and showed acanthosis rather than necrosis; on the basis of these features the infection was classified as chromoblastomycosis. The new species Rhinocladiella tropicalis is a cryptic species close to R. phaeophora and R. aquaspersa. Rhinocladiella phaeophora was known from a single strain recovered from maize field soil in Colombia [35]. It has recently been reported from a case of human chromoblastomycosis, but the sequence of this strain was not available for comparison [36]. This report nevertheless suggests that all members of the cluster consistently are able to cause chromoblastomycosis when inoculated into human skin. Rhinocladiella aquaspersa is a classical agent of chromoblastomycosis, nearly all cases having been reported from the American continent [19], but the majority of historical clinical cases have not been verified by sequence data. Strain CBS 132913 was originally reported as R. aquaspersa but was found to be 100% identical with R. tropicalis. The three species are phenotypically and clinically similar, but their sequence diversity interferes with molecular recognition of R. aquaspersa as a single species. According to Chen et al. [37] the term ‘species complex’ could be applied used to indicate closely related species do not seem to differ in clinically relevant parameters. The present rhinocladiella-like lineages have sufficient molecular distance to be recognized as species, but additional studies of antifungal susceptibility, clinical course, virulence and physiology are needed to verify significance of distinction of the three agents as individual species in hospital routine. Chromoblastomycosis is clinically highly variable, with six different clinical types [8, 38]. Despite the polymorphic nature of lesions, common factor at the patient side is the absence of necrosis and often even hyper-growth of dermal tissues, which distinguishes the disease from its clinical counterpart, phaeohyphomycosis. At the fungal side, the invasive form is the muriform cell, which is likely to be the cause of the growth-promoting dermal response. As such the disease is polyphyletic within the Chaetothyriales, but has not or extremely rarely been observed outside this order. In both cases caused by these two new species here described it was encountered polymorphic lesions frequently related to clinical cases of chromoblastomycosis [8]. In the State of Maranhão, Brazil, five chaetothyrialean agents of chromoblastomycosis are endemic. A potential source of infection has been suggested [39] to be the harvest of babassu coconuts from a wild palm tree (Orbignya phalerata). A large part of the local rural population is involved in the collection of nuts to extract babassu oil, an important component for local and international beauty product manufacturers. Members of Chaetothyriales are indeed enriched on babassu shell fragments, which are considered a risk factor for developing chromoblastomycosis after trauma sustained at work [39, 40]. A direct link between shells and agents of the disease has however not unambiguously been established. In other Brazilian regions the number of new cases of chromoblastomycosis is decreasing [8, 41, 42]. This is thought to reflect changes in agricultural practices, the extensive use of agricultural antifungals, especially azole derivatives, and the progressive mechanization of plantations resulting in a reduction of the risk of occupational exposure [8, 43, 44]. Our results showed that C. ludoviensis and R. tropicalis had their optimal development at 30 and 27°C, respectively, the maximum growth temperature of all strains analyzed being at 37°C. The chronic nature of the infection corresponds with borderline survival of the fungus in tissue. Epidermal temperatures are usual below 37°C, allowing infection by fungi that barely support this temperature. This agrees with the clinical observation that members of the Cyphellophoraceae (‘europaea-clade’), which have their maximum growth at 36°C, cause only mild, superficial infections, having a very low degree of invasive ability and virulence [22]. According to the World Health Organization (WHO) [45] the Neglected Tropical Diseases include a series of endemic diseases that prevail in tropical or subtropical areas worldwide. The prevalence of causative microbes is linked to poverty and disadvantage. However, fungal diseases were still not included in this list, except mycetoma, another implantation mycosis [46]. Chromoblastomycosis has been reported in the literature as an overlooked disease [11]. Its global burden is comparable to or greater than that of mycetoma. Considering to its global distribution, its impact on the impoverished, and its refractoriness, it also should be considered a true neglected disease as defined by WHO.

Materials and methods

Strains studied

Strains analyzed comprised 123 clinical isolates (Table 1) from different cases and several endemic areas in Brazil, with viable cultures for molecular epidemiology studies and with detailed registration data deposited in medical file systems of the institutions involved in this study. All the clinical strains were deposited at Microbial Collections of Paraná Network- TAXon line at Federal University of Paraná, the register numbers, others nomenclature references and additional information were informed in the Table 1. The Holotype number was provided from Department of Botany Herbarium at Federal University of Paraná (UPCB), TAXon line collections network (http://taxonline.nerdweb.com.br/), register number at http://www.splink.org.br/. This work was approved by the Research Ethics Committee-CEP-HUUFMA (University Hospital of the Federal University of Maranhão), according to Brazilian Resolution -Approval number: 1.276.342. All samples were anonymized. The set was supplemented with reference strains from the Centraalbureau voor Schimmelcultures (CBS/KNAW) Fungal Biodiversity Centre, Utrecht, Netherlands and the strain previously described as R. aquaspersa CBS 132913 was included in the phylogenetic analysis. Stock cultures were maintained in slants of 2% malt extract agar (MEA) and oatmeal agar (OA) at 24°C. For morphological studies, MEA and potato dextrose agar (PDA) slide cultures were prepared and mounted in aniline blue.

Physiology

Cardinal growth temperatures were determined on 2% MEA. Plates were incubated in the dark for 3 weeks at a 3–36°C temperature range with intervals of 3°C; growth was also recorded at 14, 37, 38, 39 and 40°C. Growth rates per species were obtained by calculation of the average growth of all isolates proven to belong to that species, including the respective standard deviations. Results were plotted with temperature (°C) versus colony diameter (mm) as parameters. Optimum range (= average ± standard deviation) and maximum growth temperatures were determined using the type strains of each species with three replicates averages of three measurements were calculated. Different temperatures were tested, at 28°C was observed the largest number of structures to Chyphellophora and it was used to describe the species morphology.

DNA extraction and amplification

DNA extraction and quality tests were performed using glass beads (Sigma G9143) according to protocols described previously [23] and when it was required, the purification of DNA was undertaken using the UltraClean™ Microbial DNA Kit (MO Bio, Carlsbad, CA, USA) according to manufacturer’s instructions. Colonies were cultivated on Sabouraud’s glucose agar (SGA). The partial large subunit of the nuclear ribosomal RNA gene (LSU) was amplified using primers NL1 and LR5 [22] for phylogenetic assessment. Three gene regions were chosen for species delimitation: rDNA Internal Transcribed Spacer (ITS), and the partial genes cell division cycle gene (CDC42) and β-tubulin (BT2). ITS amplicons were generated with primers V9G and LS266 [47, 48] and were sequenced with primers ITS1 and ITS4. CDC42 amplification and sequencing was generated with cdc42w and cdc42f [49] and BT2 amplification and sequencing was generated with Bt-2a and T2 [50]. PCR was performed in a 12.5 μL volume of a reaction mixture containing 1× PCR buffer, 2.0 mM MgCl2, 25 μM dNTPs, 0.5 μM of each forward and reverse primers, 1 U of BioTaq DNA polymerase, and 10 ng of genomic DNA. Amplification was performed in an ABI PRISM 2720 (Applied Biosystems, Foster City, USA) thermocycler as follows: 95°C for 4 min, followed by 35 cycles consisting of 95°C for 45s, 52°C for 30s and 72°C for 2 min, and a delay at 72°C for 7 min. Annealing temperatures were changed to 52°C, 55°C and 58°C for ITS, CDC42 and BT2 respectively. Amplicons were cleaned with Exonuclease I and Shrimp Alkaline Phosphatase (SAP) according to manufacturer’s instructions. Amplicons were sequenced with a BigDye Terminator Cycle Sequencing Kit v. 3.1 (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s instructions, reactions were purified with Sephadex G-50 fine (GE Healthcare Bio-Sciences, Uppsala, Sweden) and sequences were analysed on an ABI Prism 3700 DNA Sequencer (Perkin-Elmer, Norwalk, Foster City, CA, USA).

Phylogenetic analysis

Consensus sequences of the ITS region, BT2, CDC42, and the LSU were visually inspected using MEGA v.7 software [51]. The alignment of obtained sequences was performed using the online MAFFT interface [52]. The genes ITS, CDC42 and BT2 were first analyzed separately and for analysis of multilocus (S1 Fig). We did the LSU analyses to assess the phylogenetic position of the species analyzed in this study. The phylogenetic analyses of the small subunit (SSU) and LSU groups previously recognized in the Herpotrichiellaceae by de Hoog et al. [21], Feng et al. [22] and Vicente et al. [23] were taken as a basis for clade delimitation. Trees were constructed with 100 bootstrap replicates using the Maximum Likelihood Implemented in Mega v. 7 software [51], with the best evolutionary model to this dataset. Conflicts were estimated using the partition homogeneity test available in PAUP* v. 4.Ob10 [53]. To elucidated and explore a more detailed the clustering unnamed species, their sequences were compared to those deposited at GenBank and the CBS-KNAW sequence data sets.

Multilocus tree of Fonsecaea and Cladophialophora based on confidently aligned ITS and partial BT2 and CDC42 sequences.

Constructed with maximum likelihood implemented in MEGA 7.0. Bootstrap values of <80% from 1,000 resampled data sets are shown with branches. Cladophialophora yegresii (CBS 114406, CBS 114407 and CBS 114405) and C. carrionii (CBS 161.54, CBS 406.96, CBS 165.54 and CBS 108.97) comprised the outgroup. Fonsecaea species causing chromoblastomycosis are indicated in red. Type strain in bold. (EPS) Click here for additional data file.
  42 in total

Review 1.  Chromoblastomycosis.

Authors:  Rubén López Martínez; Luis Javier Méndez Tovar
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

2.  Cladophialophora carrionii: a rare agent of chromoblastomycosis in Rio de Janeiro State, Brazil.

Authors:  Marcelle de F Mouchalouat; Maria Clara G Galhardo; Paulo Cezar Monteiro Fialho; Janice Mery C de Oliveira Coelho; Rosely Maria Zancopé-Oliveira; Antonio Carlos F do Valle
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2008 Nov-Dec       Impact factor: 1.846

3.  CHROMOBLASTOMYCOSIS MASQUERADING AS DERMATOPHYTOSIS, WITH THE DESCRIPTION OF A NEW OPPORTUNISTIC SPECIES.

Authors:  Kowit Kampirapap; Sutthirat Reangchainam; Pornpit Ornpaew; Poohglin Tresukosol
Journal:  Southeast Asian J Trop Med Public Health       Date:  2015-01       Impact factor: 0.267

4.  Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.

Authors:  M J Najafzadeh; J Sun; V Vicente; L Xi; A H G Gerrits van den Ende; G S de Hoog
Journal:  Med Mycol       Date:  2010-09       Impact factor: 4.076

5.  Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis.

Authors:  H Badali; A Bonifaz; T Barrón-Tapia; D Vázquez-González; L Estrada-Aguilar; N M Cavalcante Oliveira; J F Sobral Filho; J Guarro; J F G M Meis; G S De Hoog
Journal:  Med Mycol       Date:  2010-08       Impact factor: 4.076

6.  Chromoblastomycosis--a clinical and mycological study of 71 cases from Sri Lanka.

Authors:  M C Attapattu
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 7.  Challenges in the therapy of chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Daniel Wagner de C L Santos
Journal:  Mycopathologia       Date:  2013-05-02       Impact factor: 2.574

Review 8.  The mycetoma knowledge gap: identification of research priorities.

Authors:  Wendy W J van de Sande; El Sheikh Maghoub; Ahmed H Fahal; Michael Goodfellow; Oliverio Welsh; Ed Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-03-27

9.  Novel evolutionary lineages revealed in the Chaetothyriales (fungi) based on multigene phylogenetic analyses and comparison of its secondary structure.

Authors:  Martina Réblová; Wendy A Untereiner; Kamila Réblová
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Biodiversity of the genus Cladophialophora.

Authors:  H Badali; C Gueidan; M J Najafzadeh; A Bonifaz; A H G Gerrits van den Ende; G S de Hoog
Journal:  Stud Mycol       Date:  2008       Impact factor: 16.097

View more
  22 in total

1.  Primary Central Nervous System Infection by Histoplasma in an Immunocompetent Adult.

Authors:  Sérgio M de Almeida; Elaine C M Imano; Vania A Vicente; Renata R Gomes; Ana P Trentin; Kassiely Zamarchi; Gabriela X Schneider; Rosangela L Pinheiro; Nickolas M da Silva; G S de Hoog
Journal:  Mycopathologia       Date:  2020-01-27       Impact factor: 2.574

Review 2.  Name Changes for Fungi of Medical Importance, 2016-2017.

Authors:  David W Warnock
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

3.  Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.

Authors:  S Deng; W Lei; G S de Hoog; L Yang; R G Vitale; H Rafati; M Seyedmousavi; A Tolooe; H van der Lee; W Liao; P E Verweij; S Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  Effect of Melanin Biosynthesis Inhibition on the Antifungal Susceptibility of Chromoblastomycosis Agents.

Authors:  Daiane Heidrich; Danielle Machado Pagani; Alessandra Koehler; Karine de Oliveira Alves; Maria Lúcia Scroferneker
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

Review 5.  Molecular Diagnosis of Two Major Implantation Mycoses: Chromoblastomycosis and Sporotrichosis.

Authors:  Danièle Maubon; Cécile Garnaud; Lala Soavina Ramarozatovo; Rapelanoro Rabenja Fahafahantsoa; Muriel Cornet; Tahinamandranto Rasamoelina
Journal:  J Fungi (Basel)       Date:  2022-04-09

6.  Correction: Molecular Epidemiology of Agents of Human Chromoblastomycosis in Brazil with the Description of Two Novel Species.

Authors: 
Journal:  PLoS Negl Trop Dis       Date:  2017-01-25

7.  Squamous cell carcinoma arising from a chromomycosis lesion caused by Rhinocladiella aquaspersa with postsurgical recurrence of chromomycosis.

Authors:  Aline Grasielli Monçale Campos; Laísa Ezaguy de Hollanda; Louise Makarem Oliveira; Fabio Francesconi do Valle; Valeska Albuquerque Francesconi do Valle
Journal:  JAAD Case Rep       Date:  2018-10-08

8.  Environmental prospecting of black yeast-like agents of human disease using culture-independent methodology.

Authors:  Flávia de Fátima Costa; Nickolas Menezes da Silva; Morgana Ferreira Voidaleski; Vinicius Almir Weiss; Leandro Ferreira Moreno; Gabriela Xavier Schneider; Mohammad J Najafzadeh; Jiufeng Sun; Renata Rodrigues Gomes; Roberto Tadeu Raittz; Mauro Antonio Alves Castro; Graciela Bolzón Inez de Muniz; G Sybren de Hoog; Vania Aparecida Vicente
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

9.  A Model for Trans-Kingdom Pathogenicity in Fonsecaea Agents of Human Chromoblastomycosis.

Authors:  Gheniffer Fornari; Renata Rodrigues Gomes; Juliana Degenhardt-Goldbach; Suelen Silvana Dos Santos; Sandro Rogério de Almeida; Germana Davila Dos Santos; Marisol Dominguez Muro; Cleusa Bona; Rosana Herminia Scola; Edvaldo S Trindade; Israel Henrique Bini; Lisandra Santos Ferreira-Maba; Daiane Rigoni Kestring; Mariana Machado Fidelis do Nascimento; Bruna Jacomel Favoreto de Souza Lima; Morgana F Voidaleski; Douglas André Steinmacher; Bruna da Silva Soley; Shuwen Deng; Anamelia Lorenzetti Bocca; Moises B da Silva; Claudio G Salgado; Conceição Maria Pedroso E Silva de Azevedo; Vania Aparecida Vicente; Sybren de Hoog
Journal:  Front Microbiol       Date:  2018-10-09       Impact factor: 5.640

10.  Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.

Authors:  Rowena Alves Coelho; Fábio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Juliana Vitoria Dos Santos Silva; Maria Clara Gutierrez-Galhardo; Antonio Carlos Francesconi do Valle; Rosely Maria Zancopé-Oliveira; Luciana Trilles; Wieland Meyer; Dayvison Francis Saraiva Freitas; Rodrigo Almeida-Paes
Journal:  PLoS Negl Trop Dis       Date:  2018-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.